Elizabeth Comen

Memorial Sloan Kettering Cancer Center

Papers

1

Total Citations

2

H-Index

1

About

No biography available yet.

Research Focus

Ablation1 · 2 citations
Breast cancer1 · 2 citations
Cancer1 · 2 citations
Chemotherapy1 · 2 citations
Cryoablation1 · 2 citations
Immunotherapy1 · 2 citations
Internal medicine1 · 2 citations
Ipilimumab1 · 2 citations
Medicine1 · 2 citations
Neoadjuvant therapy1 · 2 citations
Nivolumab1 · 2 citations
Oncology1 · 2 citations

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
2 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1
    A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
    2 citations · 2019

Key Collaborators

LNLarry Norton1 shared papersHLHeather L. McArthur1 shared papersJLJ.H.S. Leal1 shared papersMRMicaela Rodine1 shared papersDBDavid B. Page1 shared papersYBYolanda Bryce1 shared papersSBStephen B. Solomon1 shared papersCDChristina DiLauro Abaya1 shared papersSPSujata Patil1 shared papers
Not generated yet